A cost-benefit analysis of lipid standardization in the United States.

about

Effect of the Standardization of Diagnostic Tests on the Prevalence of Diabetes Mellitus and Impaired Fasting Glucose.

P2860

Q51246218-7D071A32-FBA3-465E-8CBA-A9B68CBC9D50

P2860

A cost-benefit analysis of lipid standardization in the United States.

Item

http://www.wikidata.org/entity/Q35565811

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

A cost-benefit analysis of lipid standardization in the United States.

@ast

A cost-benefit analysis of lipid standardization in the United States.

@en

type

Item

label

A cost-benefit analysis of lipid standardization in the United States.

@ast

A cost-benefit analysis of lipid standardization in the United States.

@en

prefLabel

A cost-benefit analysis of lipid standardization in the United States.

@ast

A cost-benefit analysis of lipid standardization in the United States.

@en

P1476

A cost-benefit analysis of lipid standardization in the United States

@en

P2093

John S Wittenborn

http://www.w3.org/2001/XMLSchema#string

Thomas J Hoerger

http://www.w3.org/2001/XMLSchema#string

Walter Young

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Deaths: final data for 2006.

The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements.

Life-years gained among US adults from modern treatments and changes in the prevalence of 6 coronary heart disease risk factors between 1980 and 2000.

Four frequently used test systems for serum cholesterol evaluated by isotope dilution gas chromatography-mass spectrometry candidate reference method.

Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold.

A reference method laboratory network for cholesterol: a model for standardization and improvement of clinical laboratory measurements.

P304

A136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22005629

http://www.w3.org/2001/XMLSchema#string

P932

3221577

http://www.w3.org/2001/XMLSchema#string

A cost-benefit analysis of lipid standardization in the United States.

about

P2860

P2860

A cost-benefit analysis of lipid standardization in the United States.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932